scholarly journals Proposal of a low-dose, long-pitch, dual-source chest CT protocol on third-generation dual-source CT using a tin filter for spectral shaping at 100 kVp for CoronaVirus Disease 2019 (COVID-19) patients: a feasibility study

2020 ◽  
Vol 125 (4) ◽  
pp. 365-373 ◽  
Author(s):  
Andrea Agostini ◽  
Chiara Floridi ◽  
Alessandra Borgheresi ◽  
Myriam Badaloni ◽  
Paolo Esposto Pirani ◽  
...  
2015 ◽  
Vol 84 (8) ◽  
pp. 1608-1613 ◽  
Author(s):  
Holger Haubenreisser ◽  
Mathias Meyer ◽  
Sonja Sudarski ◽  
Thomas Allmendinger ◽  
Stefan O. Schoenberg ◽  
...  

Author(s):  
Corrado Tagliati ◽  
Cecilia Lanza ◽  
Giovanni Pieroni ◽  
Lucia Amici ◽  
Marina Carotti ◽  
...  

2016 ◽  
Vol 10 (4) ◽  
pp. 282-288 ◽  
Author(s):  
Veit Sandfort ◽  
Mark A. Ahlman ◽  
Elizabeth C. Jones ◽  
Mariana Selwaness ◽  
Marcus Y. Chen ◽  
...  

2021 ◽  
pp. 028418512110032
Author(s):  
Sebastian Zensen ◽  
Denise Bos ◽  
Marcel Opitz ◽  
Johannes Haubold ◽  
Michael Forsting ◽  
...  

Background In the assessment of diseases causing skeletal lesions such as multiple myeloma (MM), whole-body low-dose computed tomography (WBLDCT) is a sensitive diagnostic imaging modality, which has the potential to replace the conventional radiographic survey. Purpose To optimize radiation protection and examine radiation exposure, and effective and organ doses of WBLDCT using different modern dual-source CT (DSCT) devices, and to establish local diagnostic reference levels (DRL). Material and Methods In this retrospective study, 281 WBLDCT scans of 232 patients performed between January 2017 and April 2020 either on a second- (A) or third-generation (B) DSCT device could be included. Radiation exposure indices and organ and effective doses were calculated using a commercially available automated dose-tracking software based on Monte-Carlo simulation techniques. Results The radiation exposure indices and effective doses were distributed as follows (median, interquartile range): (A) second-generation DSCT: volume-weighted CT dose index (CTDIvol) 1.78 mGy (1.47–2.17 mGy); dose length product (DLP) 282.8 mGy·cm (224.6–319.4 mGy·cm), effective dose (ED) 1.87 mSv (1.61–2.17 mSv) and (B) third-generation DSCT: CTDIvol 0.56 mGy (0.47–0.67 mGy), DLP 92.0 mGy·cm (73.7–107.6 mGy·cm), ED 0.61 mSv (0.52–0.69 mSv). Radiation exposure indices and effective and organ doses were significantly lower with third-generation DSCT ( P < 0.001). Local DRLs could be set for CTDIvol at 0.75 mGy and DLP at 120 mGy·cm. Conclusion Third-generation DSCT requires significantly lower radiation dose for WBLDCT than second-generation DSCT and has an effective dose below reported doses for radiographic skeletal surveys. To ensure radiation protection, DRLs regarding WBLDCT are required, where our locally determined values may help as benchmarks.


Sign in / Sign up

Export Citation Format

Share Document